Intracerebral Hemorrhage Linked to Increased Risk of Cognitive Decline at Young Age
This was a retrospective cohort study that compared the risk of dementia in young patients with traumatic compared with spontaneous intracerebral hemorrhage.
AAN 2021
Rimegepant Reduces Analgesic and Antiemetic Use by Adults With Migraine
Study investigators sought to determine whether acute treatment with rimegepant decreases analgesic or antiemetic use in people with migraine.
Efgartigimod Well Tolerated and Effective for Myasthenia Gravis
Efgartigimod may be an effective and well-tolerated treatment option for patients with myasthenia gravis.
Comparing Mindfulness Meditation With Headache Education for Migraine
Researchers presented their study results comparing headache education with mindfulness-based stress reduction for patients with migraine at the AAN 2021 Virtual Annual Meeting,
NfL Levels May Predict Cognitive Decline and Neuroimaging Changes
At the AAN 2021 Virtual Annual Meeting, investigators presented their study findings comparing plasma neurofilament light (NfL) and T-tau levels in predicting cognitive decline.
ADS-5102 Reduces Time with Dyskinesia and Increases ON Time in Parkinson Disease
This post-hoc analysis detailed the effects of ADS-5102 on ON time and dyskinesia in patients with Parkinson Disease.
Infective Endocarditis With Subarachnoid Hemorrhage Linked to Higher Risk of Stroke, Mortality
During the AAN 2021 Virtual meeting, researchers presented their study on infective endocarditis and the rate of acute ischemic stroke in patients with and without subarachnoid hemorrhage.
Treatment With Interferon Reduces Risk for Severe COVID-19 in Patients With MS
In an abstract presented at AAN 2021, researchers described the effect of disease-modifying therapies on COVID-19 severity in patients with COVID-19 and multiple sclerosis.
Plasma von Willebrand Factor Levels May Be Useful as Biomarkers in Traumatic Brain Injury
In an abstract presented at AAN 2021, researchers demonstrated the use of von Willebrand Factor as a biomarker of traumatic brain injury.
Brain Tumor Location, Grade Influence Sleep Disturbances After Treatment
A team of researchers analyzed clinical characteristics and sleep parameters in adult patients with primary brain tumors experiencing symptoms of sleep disturbance.
- Loading...
Loading...
Next post in AAN 2021
Loading... 
Loading...